A key component of the Patient Protection and Affordable Care Act (PPACA) of 2010 has just been released with little fanfare. One of the most significant provisions in the law gives the Food and Drug Administration (FDA) the authority to regulate biosimilars
Read More...
Read the complete post at http://healthaffairs.org/blog/2012/02/27/fdas-draft-biosimilar-guidance-a-good-first-step/
Posted
Feb 27 2012, 08:15 AM
by
Health Affairs Blog